Doseloop Beta

Loratadine

medication Under review

A second-generation antihistamine used to treat symptoms of seasonal allergies and hives.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

Human clinical evidence shows that loratadine is effective for allergic rhinitis and chronic urticaria, with benefits demonstrated in placebo-controlled trials and broader clinical trial summaries. In healthy volunteer studies, standard doses were well tolerated, and pharmacokinetic studies showed predictable absorption and dose proportionality. The evidence base in healthy subjects supports symptomatic allergy relief as the primary benefit. There is no strong human evidence for broader general-health or performance effects, and available trials do not support use for unrelated indications such as bone pain prevention.

Reported Benefits

Reported Side Effects

Related health conditions

Research showing how this habit affects specific health conditions. Always consult healthcare professionals.

May Help With

Research (3 studies)

RCT

Clinical Trials of CLARITIN Tablets in Allergic Rhinitis

FDA Label • 2000 • n=10700

Unspecified in search result

RCT

Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria.

Unspecified in search result • 1995 • n=203

Unspecified in search result

RCT

Double-blind placebo-controlled study of loratadine, mequitazine, and placebo in the symptomatic treatment of seasonal allergic rhinitis.

Journal of Allergy and Clinical Immunology • 1987 • n=69

Unspecified in search result

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 3
Researched benefits 4
Side effects noted 2